David Rojo
David Rojo
Web of Science ResearcherID:
Bio: David Rojo obtained his PhD in Pharmacy at Universidad CEU San Pablo, Madrid (Spain). Since then, he is a Postdoctoral Researcher at CEMBIO (Madrid, Spain). He has developed his expertise in analytical chemistry with special interest on mass spectrometry. His current research activity is in the field of metabolomics; in particular, among other topics and projects, he is focuses on the metabolomics of gut microbiota and the data integration for systems biology. He has directed several Master projects. He authored more than 30 scientific articles in journals included in JCR and 3 book chapters. Up to date, his research has received more than 1,000 cites.
Publications by David Rojo:
Metabolic profiling of Alzheimer’s disease: Untargeted metabolomics analysis of plasma samples
Posted on: 16 Jul 2023
Further Insights into the Gut Microbiota of Cow’s Milk Allergic Infants: Analysis of Microbial Functionality and Its Correlation with Three Fecal Biomarkers
Posted on: 25 May 2023
Relationship between 4-Hydroxynonenal (4-HNE) as Systemic Biomarker of Lipid Peroxidation and Metabolomic Profiling of Patients with Prostate Cancer
Posted on: 10 Ene 2023
Targeting the Gut Microbiota of Vertically HIV-Infected Children to Decrease Inflammation and Immunoactivation: A Pilot Clinical Trial
Posted on: 26 Feb 2022
Ceramide Composition in Exosomes for Characterization of Glioblastoma Stem-Like Cell Phenotypes
Posted on: 21 Ene 2022
Unravelling the Gut Microbiota of Cow’s Milk–Allergic Infants, Their Mothers, and Their Grandmothers
Posted on: 14 Ene 2022
Metabolomic changes after DAAs therapy are related to the improvement of cirrhosis and inflammation in HIV/HCV-coinfected patients
Posted on: 12 Ene 2022
Blood microbiome is associated with changes in portal hypertension after successful direct-acting antiviral therapy in patients with HCV-related cirrhosis
Posted on: 09 Dic 2021
Gas Chromatography–Mass Spectroscopy-Based Metabolomics Analysis Reveals Potential Biochemical Markers for Diagnosis of Gestational Diabetes Mellitus
Posted on: 19 Nov 2021
Low and high resolution gas chromatography-mass spectrometry for untargeted metabolomics: A tutorial
Posted on: 09 Sep 2021
Metabolomics reveals synergy between Ag and g-C3N4 in Ag/gC3N4 composite photocatalysts: a unique feature among Ag-doped biocidal materials
Posted on: 01 Jun 2021
Utilization of low molecular weight organic compounds by the filterable fraction of a lotic microbiome
Posted on: 02 Dic 2020
Sample pre-treatment procedures for the omics analysis of human gut microbiota: Turning points, tips and tricks for gene sequencing and metabolomics
Posted on: 30 Nov 2020
Use of Flavin-Containing Monooxygenases for Conversion of Trimethylamine in Salmon Protein Hydrolysates
Posted on: 24 Nov 2020
Metabolomics analysis of microbiota-gut-brain axis in neurodegenerative and psychiatric diseases
Posted on: 21 Nov 2020
A body weight loss- and health-promoting gut microbiota is established after bariatric surgery in individuals with severe obesity
Posted on: 06 Nov 2020
Plasma metabolomic fingerprint of advanced cirrhosis stages among HIV/HCV‐coinfected and HCV‐monoinfected patients
Posted on: 27 Jun 2020
Genetically engineered proteins with two active sites for enhanced biocatalysis and synergistic chemo- and biocatalysis
Posted on: 16 Dic 2019
Functional microbiome deficits associated with ageing: Chronological age threshold
Posted on: 15 Nov 2019
Recent Developments along the Analytical Process for Metabolomics Workflows
Posted on: 18 Oct 2019
Bioprospecting Reveals Class III ω-Transaminases Converting Bulky Ketones and Environmentally Relevant Polyamines
Posted on: 09 Ene 2019
Metabolomics analysis of leishmania by capillary electrophoresis and mass spectrometry
Posted on: 13 Nov 2018
Flow Cytometry Has a Significant Impact on the Cellular Metabolome
Posted on: 26 Oct 2018
Effects of HIV, antiretroviral therapy and prebiotics on the active fraction of the gut microbiota
Posted on: 19 Jun 2018
Interplay between gut microbiota metabolism and inflammation in HIV infection
Posted on: 23 May 2018
Metabolomic-Based Methods in Diagnosis and Monitoring Infection Progression
Posted on: 07 Abr 2018
Metabolic and evolutionary patterns in the extremely acidophilic archaeon Ferroplasma acidiphilum YT
Posted on: 16 Jun 2017
Antibiotic use and microbiome function
Posted on: 15 Jun 2017
Phenotyping of gut microbiota: Focus on capillary electrophoresis
Posted on: 12 Jun 2017
Exploring the human microbiome from multiple perspectives: Factors altering its composition and function
Posted on: 25 Feb 2017
The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects
Posted on: 21 Dic 2016